Elizabeth H.Z. Thompson

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Elizabeth H.Z. Thompson:

Company Role Class Num Shares Value Price $ Report Date Ownership
ACADIA PHARMACEUTICALS INC EVP, Head of Research & Dev Restricted Stock Units 29,548 $489,676 $18.23 06 Mar 2026 Direct
IGM Biosciences, Inc. Director Common Stock 0 $0 $1.33 14 Aug 2025 Direct
ACADIA PHARMACEUTICALS INC EVP, Head of Research & Dev Stock Option (Right to Buy) 101,574 06 Mar 2026 Direct
Horizon Therapeutics Public Ltd Co EVP, Research & Development Ordinary Shares 0 $116.50 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Research & Development Performance Restricted Stock Units 0 06 Oct 2023 Direct
Horizon Therapeutics Public Ltd Co EVP, Research & Development Restricted Stock Units 0 06 Oct 2023 Direct

Insider Reports Filed by Elizabeth H.Z. Thompson

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ACAD ACADIA PHARMACEUTICALS INC 06 Mar 2026 2 $0 4 EVP, Head of Research & Dev 10 Mar 2026, 18:00
IGMS IGM Biosciences, Inc. 14 Aug 2025 1 $0 4 Director 14 Aug 2025, 17:25
IGMS IGM Biosciences, Inc. 30 Jun 2025 1 $0 4 Director 02 Jul 2025, 18:52
IGMS IGM Biosciences, Inc. 31 Mar 2025 1 $0 4 Director 02 Apr 2025, 19:01
ACAD ACADIA PHARMACEUTICALS INC 24 Mar 2025 2 $0 4 EVP, Head of Research & Dev 26 Mar 2025, 19:52
IGMS IGM Biosciences, Inc. 31 Dec 2024 1 $0 4 Director 03 Jan 2025, 17:55
IGMS IGM Biosciences, Inc. 30 Sep 2024 1 $0 4 Director 02 Oct 2024, 19:59
ACAD ACADIA PHARMACEUTICALS INC 12 Aug 2024 2 $0 4 EVP, Head of Research & Dev 13 Aug 2024, 18:05
IGMS IGM Biosciences, Inc. 28 Jun 2024 1 $0 4 Director 02 Jul 2024, 20:07
ACAD ACADIA PHARMACEUTICALS INC 04 Apr 2024 0 $0 3 EVP, Head of Research & Dev 15 Apr 2024, 18:00
IGMS IGM Biosciences, Inc. 29 Mar 2024 1 $0 4 Director 02 Apr 2024, 18:25
IGMS IGM Biosciences, Inc. 12 Mar 2024 1 $0 4 Director 14 Mar 2024, 18:03
/report/000120919123052363-thompson-elizabeth-h-z-2023-10-06 Horizon Therapeutics Public Ltd Co 06 Oct 2023 10 -$1,697,988 4 EVP, Research & Development 06 Oct 2023, 18:01
IGMS IGM Biosciences, Inc. 03 Oct 2023 1 $0 4 Director 05 Oct 2023, 19:43
IGMS IGM Biosciences, Inc. 03 Oct 2023 0 $0 3 Director 05 Oct 2023, 19:42
/report/000120919123018502-thompson-elizabeth-h-z-2023-03-13 Horizon Therapeutics Public Ltd Co 13 Mar 2023 1 $0 4 EVP, Research & Development 14 Mar 2023, 16:45
/report/000120919123002435-thompson-elizabeth-h-z-2023-01-04 Horizon Therapeutics Public Ltd Co 04 Jan 2023 1 $0 4 EVP, Research & Development 06 Jan 2023, 16:43
/report/000120919123000896-thompson-elizabeth-h-z-2022-12-30 Horizon Therapeutics Public Ltd Co 30 Dec 2022 5 -$1,075,296 4 EVP, Research & Development 04 Jan 2023, 15:18
/report/000120919122042767-thompson-elizabeth-h-z-2022-07-19 Horizon Therapeutics Public Ltd Co 19 Jul 2022 3 -$510,598 4 EVP, Research & Development 20 Jul 2022, 18:19
/report/000120919122041840-thompson-elizabeth-h-z-2022-07-07 Horizon Therapeutics Public Ltd Co 07 Jul 2022 1 -$6,971 4 EVP, Research & Development 11 Jul 2022, 18:03
/report/000120919122024924-thompson-elizabeth-h-z-2022-04-18 Horizon Therapeutics Public Ltd Co 18 Apr 2022 1 -$936,453 4 EVP, Research & Development 20 Apr 2022, 16:13
/report/000120919122002295-thompson-elizabeth-h-z-2022-01-04 Horizon Therapeutics Public Ltd Co 04 Jan 2022 6 -$715,935 4 EVP, Research & Development 06 Jan 2022, 20:01
/report/000120919121050212-thompson-elizabeth-h-z-2021-08-05 Horizon Therapeutics Public Ltd Co 05 Aug 2021 1 -$802,025 4 EVP, Research & Development 06 Aug 2021, 17:03
/report/000120919121045062-thompson-elizabeth-h-z-2021-07-01 Horizon Therapeutics Public Ltd Co 01 Jul 2021 3 -$578,381 4 EVP, Research & Development 02 Jul 2021, 17:02
/report/000120919121031284-thompson-elizabeth-h-z-2021-04-29 Horizon Therapeutics Public Ltd Co 29 Apr 2021 0 $0 3 EVP, Research & Development 10 May 2021, 17:00